Epidemiology and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy in Finland: a nationwide cohort study

Back

ESC Premium Access

Epidemiology and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy in Finland: a nationwide cohort study

Session: Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

Topic: Hypertrophic Cardiomyopathy

Speaker: Associate Professor M. Laine (Helsinki, FI)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Associate Professor Mika Laine

Hospital District of Helsinki and Uusimaa, Helsinki (Finland)

0 follower

8 more presentations in this session

Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy

Speaker: Doctor G. Panichella (Florence, IT)

Functional capacity by cardiopulmonary exercise testing is not related to health status in obstructive hypertrophic cardiomyopathy

Speaker: Doctor L. Bjerregaard (Aarhus, DK)

Hemodynamic effects of right and biventricular pacing during exercise in hypertrophic obstructive cardiomyopathy

Speaker: Doctor T. Ahmed (Oslo, NO)

Evaluation of clinical need, effectiveness, and safety of the first myosin inhibitor mavacamten in real world patients

Speaker: Doctor L. Seuthe (Cologne, DE)

Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany

Speaker: Associate Professor F. Sedaghat-Hamedani (Heidelberg, DE)

Access the full session

Hypertrophic obstructive cardiomyopathy (HOCM): clearing the roadblock

Speakers: Associate Professor M. Laine, Doctor G. Panichella, Doctor L. Bjerregaard, Doctor T. Ahmed, Doctor L. Seuthe...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources